Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9211 |
High Similarity |
NPD5283 |
Phase 1 |
0.8926 |
High Similarity |
NPD2981 |
Phase 2 |
0.888 |
High Similarity |
NPD3027 |
Phase 3 |
0.8852 |
High Similarity |
NPD2982 |
Phase 2 |
0.8852 |
High Similarity |
NPD2983 |
Phase 2 |
0.872 |
High Similarity |
NPD3018 |
Phase 2 |
0.8382 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.8217 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8195 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.8175 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.814 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.813 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.8106 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8106 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8095 |
Intermediate Similarity |
NPD3705 |
Approved |
0.8077 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8074 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.8015 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7955 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7955 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7955 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7955 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7953 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7934 |
Intermediate Similarity |
NPD228 |
Approved |
0.7794 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7794 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7786 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7769 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7769 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7762 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD4749 |
Approved |
0.768 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7669 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7655 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7655 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7638 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7623 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7619 |
Intermediate Similarity |
NPD37 |
Approved |
0.7612 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7581 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7569 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7556 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7556 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7556 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7552 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7541 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7533 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7518 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.75 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7482 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7482 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7467 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7467 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7463 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7445 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7445 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7442 |
Intermediate Similarity |
NPD1651 |
Approved |
0.744 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7434 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7424 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7417 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.74 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7395 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7386 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7385 |
Intermediate Similarity |
NPD17 |
Approved |
0.7383 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7368 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7365 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7365 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7353 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7343 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7343 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7339 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7324 |
Intermediate Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.7319 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7319 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7311 |
Intermediate Similarity |
NPD3020 |
Approved |
0.731 |
Intermediate Similarity |
NPD5297 |
Approved |
0.731 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7292 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.729 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7266 |
Intermediate Similarity |
NPD6387 |
Discontinued |
0.7254 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7252 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7252 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7237 |
Intermediate Similarity |
NPD6788 |
Approved |
0.7237 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7226 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7218 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7211 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7203 |
Intermediate Similarity |
NPD2808 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD5090 |
Approved |
0.72 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7194 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD846 |
Approved |
0.719 |
Intermediate Similarity |
NPD940 |
Approved |
0.7183 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7183 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7183 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7183 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7179 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7177 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7176 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7176 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7164 |
Intermediate Similarity |
NPD1669 |
Approved |
0.7153 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7153 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7152 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD8252 |
Approved |
0.7152 |
Intermediate Similarity |
NPD8251 |
Approved |
0.7143 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD1424 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7132 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7132 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7121 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7121 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7121 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7113 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7111 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7107 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD4585 |
Approved |
0.7101 |
Intermediate Similarity |
NPD2669 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD7533 |
Approved |
0.7099 |
Intermediate Similarity |
NPD7534 |
Approved |
0.7097 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7095 |
Intermediate Similarity |
NPD1350 |
Approved |
0.7095 |
Intermediate Similarity |
NPD1349 |
Approved |
0.7095 |
Intermediate Similarity |
NPD1351 |
Approved |
0.709 |
Intermediate Similarity |
NPD2232 |
Approved |
0.709 |
Intermediate Similarity |
NPD2233 |
Approved |
0.709 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7077 |
Intermediate Similarity |
NPD3596 |
Phase 2 |
0.7075 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7071 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7071 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7068 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7059 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7059 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7055 |
Intermediate Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.7045 |
Intermediate Similarity |
NPD6830 |
Clinical (unspecified phase) |
0.7042 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7042 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7042 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7034 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7027 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7027 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7027 |
Intermediate Similarity |
NPD4584 |
Approved |
0.7025 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7023 |
Intermediate Similarity |
NPD1408 |
Clinical (unspecified phase) |
0.7014 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7014 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7014 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7013 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7007 |
Intermediate Similarity |
NPD7905 |
Discontinued |
0.7007 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD4210 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD709 |
Approved |
0.7 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.6993 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6993 |
Remote Similarity |
NPD7819 |
Suspended |
0.6993 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6986 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6985 |
Remote Similarity |
NPD7258 |
Clinical (unspecified phase) |
0.6985 |
Remote Similarity |
NPD1876 |
Approved |
0.698 |
Remote Similarity |
NPD52 |
Approved |
0.698 |
Remote Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD7526 |
Approved |
0.698 |
Remote Similarity |
NPD1512 |
Approved |
0.6975
|
Remote Similarity |
NPD7240 |
Approved |